BG Medicine, Inc.
BGMDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1137
P/E Ratio—
52W High$0.0001
52W Low$0.0001
BG Medicine, Inc. (BGMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BGMD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2015-12 | 2014-12 | 2013-12 | 2012-12 | 2011-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.57M | $2.79M | $4.07M | $2.81M | $1.63M |
| Cost of Revenue | $0.51M | $0.96M | $1.39M | $0.96M | $0.62M |
| Gross Profit | $1.06M | $1.83M | $2.68M | $1.86M | $1.01M |
| Gross Margin %(computed) | 67.75% | 65.70% | 65.90% | 66.00% | 62.12% |
| Operating Expenses | |||||
| R&D Expenses | $1.77M | $2.39M | $3.73M | $7.58M | $8.00M |
| G&A Expenses | $3.62M | $4.51M | $7.13M | $7.55M | $0.00M |
| Total Operating Expenses | $5.69M | $9.19M | $17.06M | $17.00M | $18.50M |
| Operating Income | ($4.63M) | ($7.36M) | ($14.37M) | ($22.73M) | ($17.48M) |
| Operating Margin %(computed) | -295.66% | -264.16% | -352.91% | -807.39% | — |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.02M | $0.03M |
| Interest Expense | $0.16M | $0.73M | $1.17M | $1.08M | $0.09M |
| Income Before Tax | ($5.30M) | ($8.06M) | ($15.85M) | ($23.77M) | ($17.52M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | ($0.32M) |
| Net Income | ($5.30M) | ($8.06M) | ($15.85M) | ($23.77M) | ($17.58M) |
| Net Margin %(computed) | -338.63% | -289.34% | -389.12% | -844.37% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.55 | $-0.99 | $-2.33 | $-4.70 | $-3.99 |
| Wtd Avg Shares | 9.61M | 8.18M | 6.80M | 5.05M | 4.41M |
| EBITDA | ($5.06M) | ($7.21M) | ($14.76M) | ($22.41M) | ($17.07M) |
| EBITDA Margin %(computed) | -322.92% | -258.52% | -362.29% | -796.20% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more BG Medicine, Inc. data
About BG Medicine, Inc. (BGMD) Income Statement
BG Medicine, Inc. (BGMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2015, BGMD reported revenue of $0.00B, gross profit of $0.00B (gross margin 67.75%), and net income of ($0.01B) — a net profit margin of -338.63%.
Frequently asked questions
BGMD · 4 questionsBG Medicine, Inc. (BGMD) reported revenue of $0.00B for 2015, down 43.8% year-over-year.
BGMD revenueBGMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08